Marc has been advising large investors and companies on digital health strategy, investment, and M&A (both buy and sell side) since early 2015.

Marc's dedication to the digital health sector shines through in his work as a facilitator of M&A (both buy and sell side), growth investment, and strategic partnerships. He is currently involved in several digital health investment opportunities and M&A dealings. He advises large investors and life sciences companies in relation to M&A and investment in digital health.

His work focuses on assisting digital health companies in achieving growth and successful exits. Marc brings to the table more than 20 years of experience in the Life Sciences industry, including his roles in information enabled business models at IQVIA, Life Sciences management consulting at Accenture, and biotech at MerckSerono. His most recent position was overseeing M&A and digital health partnerships at Oracle Health Sciences.

Marc, a Swiss/Dutch national residing in Switzerland, studied Business Administration at Erasmus Rotterdam in the Netherlands and in France. He also undertook executive education at renowned institutions such as IMD, Insead, and the London Business School.